| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2364.7 | 2265.0 | 2007.2 |
| Other income | 4.4 | 8.3 | 19.8 |
| Total income | 2369.1 | 2273.3 | 2027.0 |
| Profit before exceptional items & tax | 336.7 | 311.6 | 290.1 |
| Exceptional items | -12.5 | -45.9 | -53.6 |
| Profit before tax | 324.2 | 265.7 | 236.6 |
| Net profit | 271.2 | 197.4 | 188.0 |
| Operating margin | 13.7% | 11.7% | 11.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +44.30% |
|---|---|
| Net profit, quarter on quarter | +37.40% |
| Revenue, year on year | +17.80% |
BSE results filing, NSE: FORTIS. Figures extracted from the filing.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹837.85
- Market cap
- ₹63,254 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 60.4×Sector 57.8×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 25.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Legal & Regulatory
Northern TK Venture Pte Ltd, Fortis Healthcare's promoter, has appealed a Tokyo District Court judgment to the Tokyo High Court. The litigation concerns losses related to delayed tender offer approvals.
Fortis Healthcare Partnership
Fortis Hospotel signed definitive agreements with SLJ Society to provide healthcare services at their 400+ bed hospital. Fortis will provide a ₹567 Crore loan.
- Value
- ₹567.0 Cr
- From
- Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society)
- hospital beds
- 400.0 beds
Fortis Healthcare Legal & Regulatory
Tokyo District Court dismissed all NTK claims against Daiichi Sankyo; NTK must bear litigation costs. NTK is reviewing the judgment and evaluating appeal options.
Fortis Healthcare Earnings Call Transcript: Key Takeaways
Management conference call discussing a Delhi High Court order regarding a forensic audit. Operating plans, including capex, bed expansion, and M&A, remain unaffected and fully funded by internal accruals.
Fortis Healthcare Investor Presentation: Key Takeaways
Fortis Q1FY27 consolidated revenue grew 17.5% YoY to INR 2,545 Cr. Consolidated Operating EBITDA rose 15.8% to INR 568 Cr with a 22.3% margin.
Fortis Healthcare Q1 FY27 Results: Net Profit ₹272.8 Cr, Up 2.2% YoY
Fortis Healthcare Ltd reported revenue from operations of ₹2,545 Cr (+17.5% YoY) and net profit of ₹272.8 Cr (+2.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹272.8 Cr · +2.2% YoY